We use cookies to personalise content and ads, to provide social media features and to analyse our traffic. We may also share information about your use of our site with our social media, advertising and analytics partners. Read more about our Privacy Policy.

I got it!

Dr Mikko Hölttä

Senior Research Scientist

Dr. Mikko Hölttä joined AstraZeneca Gothenburg in March 2015 as senior scientist in the nucleotide bioanalysis group, working with pre-clinical PK/TK bioanalysis for new modality projects including oligonucleotides, modified RNA, CRISPR-CAS9, anti-miR, and proteins/peptides. Since March 2017, he has been working in the translational biomarkers & bioanalysis team in AZ Gothenburg providing analytical support for new
modality projects and with development and validation of biomarkers for safety studies.
He received his Ph.D. in medicine in 2014, working with clinical biomarkers discovery for Alzheimer’s disease and other neurogenerative diseases from Sahlgrenska Academy, University of Gothenburg, and then continued to work as a research scientist in neuroscience & physiology. He has a master’s degree in pharmaceutical biosciences from Sahlgrenska Academy in 2008.

Similar Speakers

Mr Casper Uldriks
Speaker

17

Mr Michael Brodsky
Speaker

11

Mr Camelia-Margareta Bogdanici
Organizing Member

6

Mr Dan Oleary
Researcher

4

Mr John N Zorich
Statistical Consultant & Trainer

4

Mr Betty Lane
Speaker

4

Mr Intima Alrimawi
Keynote Speaker

3

Mr Ricardo Valls
President

2

Mr Jean-Claude Combadazou
Dental Surgeon / Speaker

2

Mr Jean-Christophe Paris
Dental Surgeon / Speaker

2

Mr André-Jean Faucher
Dental Surgeon / Speaker

2

Mr Jerry Lanese
Independent consultant

2

Mr Christophe Ghrenassia
Dental Surgeon / Speaker

2

Mr sam vaknin
Keynote speaker, Workshop

1

Ms Haza Marion
keynote speaker

1

Mrs Jo Anna Ferrie
Keynote Speaker

1

Mr Claudia A Chiriboga
Keynote Speaker

1

Register for free to access the Speakers Directory

Search by policy area and keyword 3107 professional speakers from Europe and beyond